Cutaneous side-effects of kinase inhibitors and blocking antibodies-Reference-Cited by-同舟云学术

Cutaneous side-effects of kinase inhibitors and blocking antibodies

Published:2005-07 Issue:7 Volume:6 Page:491-500
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Robert Caroline,Soria Jean-Charles,Spatz Alain,Le Cesne Axel,Malka David,Pautier Patricia,Wechsler Janine,Lhomme Catherine,Escudier Bernard,Boige Valérie,Armand Jean-Pierre,Le Chevalier Thierry

Publisher

Elsevier BV

Subject

Oncology

Reference76 articles.

1. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors;Demetri;N Engl J Med,2002

2. Can rash associated with HER1/EGFR inhibition be used as a marker of treatment outcome?;Perez-Soler;Oncology (Huntingt),2003

3. Tyrosine kinase inhibition and grey hair;Robert;Lancet,2003

4. Gefitinib: a novel targeted approach to treating cancer;Herbst;Nat Rev Cancer,2004

5. Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer;Mendelsohn;J Clin Oncol,2003

Cited by 461 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of Skin Toxicities in Cancer Treatment: An Australian/New Zealand Perspective;Cancers;2024-07-12

2. An engineering strategy to target activated EGFR with CAR T cells;Cell Reports Methods;2024-04

3. Acquired Disorders of Hair;Rook's Textbook of Dermatology;2024-03-19

4. Dolutegravir-induced hand–foot skin reaction in a seropositive male: A rare presentation;Indian Journal of Pharmacology;2024-01

5. The Future Prospects in Effective Management of Glioblastoma Multiforme Using Exosomes: A Comprehensive Review;Handbook of Neurodegenerative Disorders;2024